To explore the potential roles of ARNTL2 in the TIME of ccRCC, we initially assessed the associations of the expression of ARNTL2 and its top three co-expressed genes with various tumor infiltrated immune cell types in ccRCC. Here, BMAL2 is linked to nonpapillary renal cell carcinoma.